Enrique Sendagorta Gomendio
Directeur/Membre du Conseil chez Proyecto de Biomedicina CIMA SL
Profil
Enrique Sendagorta Gomendio is currently the Director at Proyecto de Biomedicina CIMA SL.
He was previously the Chairman at Metabolic Renal Disease SL.
He also held positions such as Operations Director at GM Searle, Director-Business Development at Pharmacias, Vice President-Operations at Bristol Myers Squibb Co., and Principal at Hoffman Corp.
Mr. Sendagorta Gomendio holds an MBA from New York University and an undergraduate degree from Universidad Complutense de Madrid.
Postes actifs de Enrique Sendagorta Gomendio
| Sociétés | Poste | Début |
|---|---|---|
Proyecto de Biomedicina CIMA SL
 Proyecto de Biomedicina CIMA SL Miscellaneous Commercial ServicesCommercial Services Proyecto de Biomedicina CIMA SL is a holding company engaged in the provision of product licensing and intellectual property rights management services. It holds patents generated by the Centro de Investigacion Medica Aplicada, which have indications across the clinical fields of oncology, hepatology, dermatology, and gene therapy. The company was founded in June 2003 and is headquartered in Pamplona, Spain. | Directeur/Membre du Conseil | - |
Anciens postes connus de Enrique Sendagorta Gomendio
| Sociétés | Poste | Fin |
|---|---|---|
| GM Searle | Directeur des opérations | 01/01/2002 |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur des opérations | - |
| Pharmacias | Corporate Officer/Principal | - |
Hoffman Corp.
 Hoffman Corp. Engineering & ConstructionIndustrial Services Hoffman Corp. provides general contracting services for nonresidential building construction. It also provides plumbing and heating, ventilation and air-conditioning, installation, electrical wiring, surveying, and concrete contracting services. The company was founded by L. H. Hoffman in 1922 and is headquartered in Portland, OR. | Corporate Officer/Principal | - |
Metabolic Renal Disease SL
 Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain. | President | - |
Formation de Enrique Sendagorta Gomendio
| New York University | Masters Business Admin |
| Universidad Complutense de Madrid | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 5 |
|---|---|
Hoffman Corp.
Hoffman Corp. Engineering & ConstructionIndustrial Services Hoffman Corp. provides general contracting services for nonresidential building construction. It also provides plumbing and heating, ventilation and air-conditioning, installation, electrical wiring, surveying, and concrete contracting services. The company was founded by L. H. Hoffman in 1922 and is headquartered in Portland, OR. | Industrial Services |
Proyecto de Biomedicina CIMA SL
Proyecto de Biomedicina CIMA SL Miscellaneous Commercial ServicesCommercial Services Proyecto de Biomedicina CIMA SL is a holding company engaged in the provision of product licensing and intellectual property rights management services. It holds patents generated by the Centro de Investigacion Medica Aplicada, which have indications across the clinical fields of oncology, hepatology, dermatology, and gene therapy. The company was founded in June 2003 and is headquartered in Pamplona, Spain. | Commercial Services |
Metabolic Renal Disease SL
Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain. | Health Technology |
| GM Searle | |
| Pharmacias |